Journal of Pathology

Papers
(The H4-Index of Journal of Pathology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats91
Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer80
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer79
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment71
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities68
Issue Information64
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance63
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors63
Presence of Tim3+ and PD‐1+CD8+T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and di60
Escape from senescence: molecular basis and therapeutic ramifications55
The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients53
Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma53
Spatial profiling of ANO7 in prostate tissue: links to AR‐signalling‐associated lipid metabolism and inflammation52
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy50
Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells48
Artificial intelligence to identify genetic alterations in conventional histopathology46
CRISPR–Cas9 screening identifies the role of FER as a tumor suppressor45
Integrating computational pathology and proteomics to address tumor heterogeneity43
Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer42
Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma42
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response41
Pseudobudding: ruptured glands do not represent true tumor buds39
Silencing GRHL3 promotes multiple organ distant metastasis of lung squamous cell carcinoma cells by enhancing SOX2 stability via SIRT138
38
Field cancerization in breast cancer36
In high‐grade ovarian carcinoma, platinum‐sensitive tumor recurrence and acquired‐resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and 34
Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells33
33
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer33
Adrenomedullin2 stimulates progression of thyroid cancer in mice and humans under nutrient excess conditions32
Development of a multi‐scanner facility for data acquisition for digital pathology artificial intelligence31
Prediction of coexisting invasive carcinoma on ductal carcinoma in situ (DCIS) lesions by mass spectrometry imaging31
Issue Information31
0.029727935791016